Pages that link to "Q84748806"

The following pages link to Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts (Q84748806):

Displaying 45 items.

• European union standards for tuberculosis care (Q26823223) (← links)
• Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis (Q27000984) (← links)
• Advances in the diagnosis of tuberculosis infection (Q27002202) (← links)
• Updates on the risk factors for latent tuberculosis reactivation and their managements (Q28073158) (← links)
• Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression (Q28740799) (← links)
• Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak (Q33396678) (← links)
• Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers. (Q33638976) (← links)
• The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa (Q33867491) (← links)
• Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots (Q34128381) (← links)
• Recent Advances in Testing for Latent TB (Q34386405) (← links)
• Observational study of QuantiFERON®-TB gold in-tube assay in tuberculosis contacts in a low incidence area (Q34399197) (← links)
• IGRA as a predictive factor of silent pulmonary changes in individuals following exposure to tuberculosis (Q34545107) (← links)
• Latent tuberculosis detection by interferon γ release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children (Q34678691) (← links)
• Strategy to better select HIV-infected individuals for latent TB treatment in BCG-vaccinated population (Q34981656) (← links)
• Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis (Q35024697) (← links)
• Predictive value of interferon-gamma release assays for postpartum active tuberculosis in HIV-1-infected women (Q35118980) (← links)
• Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas (Q35336540) (← links)
• Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis (Q36301207) (← links)
• Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker (Q36384603) (← links)
• Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection (Q36438664) (← links)
• Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence (Q36637982) (← links)
• Predictive value of the tuberculin skin test among newly arriving immigrants (Q36721145) (← links)
• Immunologic diagnosis of active tuberculosis. (Q37192130) (← links)
• Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers (Q37304401) (← links)
• Gamma interferon release assays for detection of Mycobacterium tuberculosis infection (Q37544916) (← links)
• Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence (Q37649784) (← links)
• Diagnosis of tuberculosis infection using interferon-γ-based assays (Q37855146) (← links)
• Clinical Application and Limitations of Interferon- Release Assays for the Diagnosis of Latent Tuberculosis Infection (Q37860816) (← links)
• T-SPOT.TB assay usage in adults and children (Q37899891) (← links)
• QuantiFERON®-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study. (Q40074673) (← links)
• Should interferon gamma release assays become the standard method for screening patients for Mycobacterium tuberculosis infections in the United States? (Q42773052) (← links)
• Quality Improvement of Tuberculosis Screening in Foreign-Born Patients (Q43745810) (← links)
• Interferon-γ responses to Mycobacterium tuberculosis Rpf proteins in contact investigation. (Q45105159) (← links)
• Negative and Positive Predictive Value of a Whole-Blood Interferon-γ Release Assay for Developing Active Tuberculosis (Q46093848) (← links)
• Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort (Q46655776) (← links)
• Evaluating UK National Guidance for Screening of Children for TB: A Prospective Multi-centre Study (Q47203729) (← links)
• Performance of Confirmatory Interferon-γ Release Assays in School TB Outbreaks (Q51002428) (← links)
• Mycobacterial growth inhibition is associated with trained innate immunity. (Q52376102) (← links)
• Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test. (Q54241389) (← links)
• Evaluating latent tuberculosis infection diagnostics using latent class analysis (Q57093725) (← links)
• Do IFN-γ-release assays predict the risk of TB? New evidence from a study on patients with silicosis (Q57632332) (← links)
• Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study (Q58791540) (← links)
• Spectrum of latent tuberculosis — existing tests cannot resolve the underlying phenotypes (Q59200750) (← links)
• Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures (Q64098089) (← links)
• Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis (Q97556936) (← links)